| Carol A. Carter | Retroviral assembly and post-assembly |
| Josh Dubnnau | Retrotransposons and neurological disease |
| Janet Hearing | Emergent viruses and antiviral drug development |
| Patrick Hearing | Adenovirus-host cell interactions; viral vectors for human gene therapy |
| Erich Mackow | Determinants of viral pathogenesis; Hantaviruses, Dengue viruses, Zika virus, Powassan virus, SARS-CoV-2 |
| Daniel Salamango | Virus subversion of host antiviral responses; HIV-1, influenza viruses, SARS-CoV-2 |
